Blackrock Neurotech Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 190

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $200M

  • Investors
  • 23

Blackrock Neurotech General Information

Description

Developer of a neurotechnology platform designed to record bio-potentials from the central and peripheral nervous system. The company's precision electrode technology is at the core of many worldwide innovations in brain-computer interfaces and neural signal processing and stimulation, helping pioneers walk, talk, see, hear, and feel, enabling the clinical community, with innovative tools and neurotech expertise, to translate technology into novel implantable solutions that improve human lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 630 Komas Drive
  • Suite 200
  • Salt Lake City, UT 84108
  • United States
+1 (801)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Corporate Office
  • 630 Komas Drive
  • Suite 200
  • Salt Lake City, UT 84108
  • United States
+1 (801)

Blackrock Neurotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blackrock Neurotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series B1) 29-Apr-2024 $200M Completed Generating Revenue
12. Later Stage VC (Series A3) 31-Jul-2023 Completed Generating Revenue
11. Debt - PPP 01-Nov-2021 Completed Generating Revenue
10. Later Stage VC (Series B) 19-May-2021 Completed Generating Revenue
9. Later Stage VC (Series A) Completed Generating Revenue
8. Grant 01-Jun-2020 Completed Generating Revenue
7. Debt - PPP 12-Apr-2020 Completed Generating Revenue
6. Grant 10-Aug-2019 Completed Generating Revenue
5. Debt - General 01-Sep-2018 Completed Generating Revenue
4. Debt - General 01-Aug-2015 Completed Generating Revenue
To view Blackrock Neurotech’s complete valuation and funding history, request access »

Blackrock Neurotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
2023 Series A -6
2023 Series A -5
2023 Series A -4
2023 Series A -3
2023 Series A -2 13,299,308 $0.000100 6% $0.65 $0.65 1x $0.65 2.13%
2023 Series A -1 2,015,100 $0.000100 6% $1.36 $1.36 1x $1.36 0.32%
To view Blackrock Neurotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Blackrock Neurotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a neurotechnology platform designed to record bio-potentials from the central and peripheral nervous system
Therapeutic Devices
Salt Lake City, UT
190 As of 2026

San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blackrock Neurotech Competitors (5)

One of Blackrock Neurotech’s 5 competitors is EMOTIV, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EMOTIV Venture Capital-Backed San Francisco, CA
Synchron Venture Capital-Backed New York, NY
Neurable Venture Capital-Backed Boston, MA
BrainGate Venture Capital-Backed Providence, RI
Neuralink Venture Capital-Backed Fremont, CA
You’re viewing 5 of 5 competitors. Get the full list »

Blackrock Neurotech Patents

Blackrock Neurotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260114785-A1 Tile-based neural recording and stimulation system Pending 29-Oct-2024
WO-2026093922-A1 Tile-based neural recording and stimulation system Pending 29-Oct-2024
US-20260108735-A1 Systems and methods for pseudomonophasic brain stimulation Pending 23-Oct-2024
WO-2026090201-A2 Systems and methods for pseudomonophasic brain stimulation Pending 23-Oct-2024
US-20260020806-A1 Implantable embedded systems and related manufacturing methods Pending 18-Jul-2024 A61B5/293
To view Blackrock Neurotech’s complete patent history, request access »

Blackrock Neurotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blackrock Neurotech Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Redsalt Capital Family Office Minority
Streamlined Ventures Management Venture Capital Minority
Tether Investments PE/Buyout Minority
2050 Capital Venture Capital Minority
Forepont Capital Partners Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Blackrock Neurotech Investments & Acquisitions (4)

Blackrock Neurotech’s most recent deal was a Seed Round with Phantom Neuro for . The deal was made on 03-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Phantom Neuro 03-Nov-2022 Seed Round Therapeutic Devices
MindX 20-Apr-2022 Merger/Acquisition Business/Productivity Software
Phantom Neuro 25-Mar-2022 Seed Round Therapeutic Devices
BrainGate 01-Jan-2004 Merger/Acquisition Therapeutic Devices
To view Blackrock Neurotech’s complete investments and acquisitions history, request access »

Blackrock Neurotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
BrainGate Providence, RI 2000

Blackrock Neurotech FAQs

  • When was Blackrock Neurotech founded?

    Blackrock Neurotech was founded in 2008.

  • Where is Blackrock Neurotech headquartered?

    Blackrock Neurotech is headquartered in Salt Lake City, UT.

  • What is the size of Blackrock Neurotech?

    Blackrock Neurotech has 190 total employees.

  • What industry is Blackrock Neurotech in?

    Blackrock Neurotech’s primary industry is Therapeutic Devices.

  • Is Blackrock Neurotech a private or public company?

    Blackrock Neurotech is a Private company.

  • What is the current valuation of Blackrock Neurotech?

    The current valuation of Blackrock Neurotech is .

  • What is Blackrock Neurotech’s current revenue?

    The current revenue for Blackrock Neurotech is .

  • How much funding has Blackrock Neurotech raised over time?

    Blackrock Neurotech has raised $250M.

  • Who are Blackrock Neurotech’s investors?

    Redsalt Capital, Streamlined Ventures Management, Tether Investments, 2050 Capital, and Forepont Capital Partners are 5 of 23 investors who have invested in Blackrock Neurotech.

  • Who are Blackrock Neurotech’s competitors?

    EMOTIV, Synchron, Neurable, BrainGate, and Neuralink are competitors of Blackrock Neurotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process